Literature DB >> 35558984

Is the safety of azithromycin superior to other antibiotics in the treatment of infectious diseases in children?

Jiangfeng Wu1, Yinghong Guo1, Jingjing Shao1, Anli Zhao1, Yun Jin1.   

Abstract

Entities:  

Year:  2022        PMID： 35558984      PMCID： PMC9085957          DOI： 10.21037/tp-21-619

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  4 in total

1.  Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.

Authors:  Lisa Saiman; Michael Anstead; Nicole Mayer-Hamblett; Larry C Lands; Margaret Kloster; Jasna Hocevar-Trnka; Christopher H Goss; Lynn M Rose; Jane L Burns; Bruce C Marshall; Felix Ratjen
Journal:  JAMA       Date:  2010-05-05       Impact factor: 56.272

2.  Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia.

Authors:  Jianlong Wang; Cun Yang
Journal:  Pak J Pharm Sci       Date:  2018-07       Impact factor: 0.684

3.  Safety of azithromycin in pediatric infectious diseases: a clinical systematic review and meta-analysis.

Authors:  Dongjin Li; Yajun Wang
Journal:  Transl Pediatr       Date:  2021-10

4.  Lung Ultrasound for the Diagnosis of Neonatal Respiratory Distress Syndrome: A Meta-analysis.

Authors:  Jiangfeng Wu; Yunlai Wang; Anli Zhao; Zhengping Wang
Journal:  Ultrasound Q       Date:  2020-06       Impact factor: 1.462
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.